scan or angiography, were enrolled from the vascular surgery department. Twelve men >60y without significant aorto-iliac disease, as confirmed by image studies, were used as controls. Exclusion criteria included neurogenic bladder dysfunction, bladder or prostate cancer, prostate surgery, pelvic radiotherapy or chronic treatment for LUTS. Participants underwent urological examination, including IPSS score to assess LUTS, uroflowmetry, postvoid residual (PVR) and prostate volume determination. Urine samples were collected from all participants and urinary NGF was measured by ELISA to explore the presence of chronic neurogenic inflammation.
scan or angiography, were enrolled from the vascular surgery department. Twelve men >60y without significant aorto-iliac disease, as confirmed by image studies, were used as controls. Exclusion criteria included neurogenic bladder dysfunction, bladder or prostate cancer, prostate surgery, pelvic radiotherapy or chronic treatment for LUTS. Participants underwent urological examination, including IPSS score to assess LUTS, uroflowmetry, postvoid residual (PVR) and prostate volume determination. Urine samples were collected from all participants and urinary NGF was measured by ELISA to explore the presence of chronic neurogenic inflammation.
RESULTS: Data are summarized in the table. Both groups were identical for age and prostate volume. BMI was slightly higher in the control group. IPSS score was statistically significant higher in the pelvic ischemia group than in controls. The IPSS difference between the two groups was 3 points. Urinary NGF/creatinine was significantly higher in the ischemic patients.
CONCLUSIONS: Severe pelvic ischemia in elderly men is associated with a significant increase in LUTS and chronic bladder neurogenic inflammation, as suggested by the increase of NGF release, a neurotrophin that may sensitize bladder primary afferents. These findings confirm the relevance of pelvic ischemia in bladder function and validate animal models of bilateral iliac artery occlusion currently under use to investigate the pathophysiologic mechanisms at stake.
Source of Funding: Portuguese Association of Urology

PD26-06 EFFICACY AND SAFETY OF MIRABEGRON ADD-ON THERAPY TO SOLIFENACIN IN OLDER PATIENT POPULATIONS WITH OVERACTIVE BLADDER
William Gibson*, Edmonton, Canada; Scott MacDiarmid, Greensbro, NC; Moses Huang, Emad Siddiqui, Chertsey, United Kingdom; Matthias St€ olzel, Leiden, Netherlands; Nurul Choudhury, Chertsey, United Kingdom; Marcus Drake, Bristol, United Kingdom INTRODUCTION AND OBJECTIVES: Older overactive bladder (OAB) patients usually have more symptom severity, comorbidity, and poorer quality of life vs younger patients. We report efficacy/safety/ tolerability of solifenacin (SOLI) + mirabegron (MIRA) vs SOLI alone in older incontinent OAB patients refractory to SOLI monotherapy from BESIDE, a randomized, double-blind, parallel group multicenter Phase 3B study (NCT01908829).
METHODS: Adults with !3 months of OAB and an average of !2 incontinence episodes/24h entered a 2-week screening/washout period before a 4-week run-in of single-blind daily SOLI 5mg. Patients remaining incontinent at baseline (BL; !1 episode during a 3-day diary) were randomized 1:1:1 to daily double-blind combination (COMBN; SOLI 5mg+MIRA 25mg, increased to 50mg at Week 4), SOLI 5mg or 10mg for 12 weeks. Primary endpoint was change from BL to end of treatment (EOT) in mean number of incontinence episodes/24h. Safety assessment included frequency of treatment-emergent adverse events (TEAEs). Pre-defined age subgroup data are reported for patients aged <65y, !65y, <75y, and !75y.
RESULTS: Reductions in mean number of incontinence episodes/24h and micturitions/24h from BL to EOT were greater with COMBN vs SOLI monotherapy across subgroups. Incontinence treatment differences between COMBN and SOLI 5mg, and micturition frequency differences between COMBN and SOLI monotherapy were consistent across subgroups, however the difference in incontinence between COMBN and SOLI 10mg was more pronounced in patients aged !65y and !75y ( 
PD26-07 URETHRAL DIVERTICULA IN WOMEN ARE ASSOCIATED WITH INCREASED URETHRA-SPHINCTER COMPLEX VOLUMES
Eskinder Solomon*, Sahar Naseeri, Sachin Malde, Mahreen Pakzad, Rizwan Hamid, Jeremy Ockrim, Tamsin Greenwell, London, United Kingdom INTRODUCTION AND OBJECTIVES: The aetiology of urethral diverticula in women is unknown. Blockage of drainage and subsequent infection of paraurethral glands have been suggested but the primary initiating pathology remains to be elucidated. We have postulated that functional obstruction secondary to a high-tone non-relaxing sphincter may be the primary initiating pathology leading to the formation of a proximal to mid-urethral diverticulum (UD). As urethral pressure profilometry is unreliable in a urethra with a diverticulum, the urethra-sphincter complex volume may be used as a proxy for the maximal urethral closure pressure. We assessed whether urethra-sphincter complex volumes in female patients with proximal to mid-UD are higher than those without.
METHODS: The clinical and MRI data of 17 women with a mean age (AE SD) of 49.4 years (AE13.2) with the ostium of the diverticulum at or proximal to 2/3 the length of the urethra were reviewed. A consultant uro-radiologist outlined the urethra-sphincter complex using pelvic axial small field of view T2-weighted MRI sequences with 3 mm slices. OsiriXÓ was used to determine the urethra-sphincter complex volume. The findings were compared with a control group consisting of 24 age matched women of mean age 50.8 years (AE 11.2 years) having MRI for unrelated conditions. RESULTS: The mean urethra-sphincter complex volume for the UD group was 10.01 cm 3 (AE6.97 cm 3 ). The mean urethra-sphincter volume of the control group was 3.92 cm3 (AE 1.60 cm 3 ). This difference was statistically significantly (p ¼ 0.01).
CONCLUSIONS: Women with proximal-urethral diverticulum have significantly higher urethra-sphincter complex volumes than those who do not. This finding suggests that high pressure in the proximal urethra during a void secondary to a high-tone non-relaxing sphincter may contribute to the formation of a urethral diverticulum.
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